£90.58

About as cheap as it gets — within 5% of the all-time low it hit 2 months ago.

£91 today · all-time low £87 (Aug 2026) · usually £91

Targeted Therapies in Cancer: An Update (Cancer Etiology, Diagnosis and Treatments)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 63 days · 63 data points (no recent data)

Historical
Generating forecast…
£91.43 £87.10 £88.04 £88.99 £89.93 £90.88 £91.82 22 August 2026 06 September 2026 22 September 2026 07 October 2026 23 October 2026
View at Amazon ↗

Price data last checked 28 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 63 days • 4 price levels

Days at Price
Current Price
14 days 17 days 22 days 10 days 0 6 11 17 22 £87 £89 £90 £91 Days at Price

Price Analysis

Most common price: £90 (22 days, 34.9%)

Price range: £87 - £91

Price levels: 4 different prices over 63 days

Description

Besides surgery, radiation therapy, endocrine therapy or chemotherapy, which were widely used in cancer patients for decades, the 21st century has seen the emergence of targeted therapy, resulting from the identification of molecular pathways in cells and their alterations in tumors. An increasing number of compounds targeting specific molecules or cancer cells have been developed and, for some of them, approved by the United States Food and Drug Administration (FDA) as well as other regulators in EU and Japan Additional new and more efficient types of compounds, are still in clinical trials, but are expected to gain future approval. More than eighty FDA-approved targeted therapies are described here, along with about eighty other promising compounds. These drugs are members of various therapy classes, including tyrosine kinase inhibitors; serine/threonine kinase inhibitors; dual specificity kinase inhibitors; lipid kinase inhibitors; poly ADP ribose polymerase inhibitors; monoclonal antibodies; microtubule targeting agents; histone deacetylase inhibitors; proteasome inhibitors; antimetabolites; immunomodulatory agents; DNA methyltransferase inhibitors; hedgehog pathway inhibitors; enzymes; protein translation inhibitors; vaccines, oncolytic viruses; chimeric antigen receptor T-cells (CAR-T); and so on. A series of companion diagnostics intended to be used as an indication for specific therapies, and approved to this aim are also mentioned. The book aims to present the broad landscape of compounds and companion diagnostics that are expected to pave the way towards a future of hope for cancer patients.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
01 April 2016
Listed Since
08 February 2016

Barcode

No barcode data available

Similar Products You Might Like

New Research on Hematological Malignancies (Cancer Etiology, Diagnosis and Treatments)
91% match

New Research on Hematological Malignancies (Cancer Etiology, Diagnosis and Treatments)

£58.64 27 Oct 2026
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1)
90% match

Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1)

£147.06 21 Oct 2026
Laryngeal Cancer: Risk Factors, Symptoms and Treatment
90% match

Laryngeal Cancer: Risk Factors, Symptoms and Treatment

Price unavailable
Gastric Peritoneal Carcinomatosis: Principles of Surgery and Treatment Options (Cancer Etiology, Diagnosis and Treatments)
90% match

Gastric Peritoneal Carcinomatosis: Principles of Surgery and Treatment Options (Cancer Etiology, Diagnosis and Treatments)

Price unavailable
Burkitt Lymphoma: Diagnosis, Risk Factors and Treatment (Cancer Etiology, Diagnosis and Treatments)
90% match

Burkitt Lymphoma: Diagnosis, Risk Factors and Treatment (Cancer Etiology, Diagnosis and Treatments)

Price unavailable
Tumors of the Central Nervous System: Clinical Aspects and Symptom Management (Neuroscience Research Progress)
89% match

Tumors of the Central Nervous System: Clinical Aspects and Symptom Management (Neuroscience Research Progress)

Price unavailable
Chronic Lymphocytic Leukemia: Diagnosis, Treatment Options & Prognosis
89% match

Chronic Lymphocytic Leukemia: Diagnosis, Treatment Options & Prognosis

Price unavailable
Advanced Cancer Therapeutics: Strategies and Technologies for Targeted Drug Delivery
89% match

Advanced Cancer Therapeutics: Strategies and Technologies for Targeted Drug Delivery

Elsevier

£153.99 20 Oct 2026
Hydrocephalus: From Diagnosis to Treatment (Neurology - Laboratory and Clinical Research Developments)
89% match

Hydrocephalus: From Diagnosis to Treatment (Neurology - Laboratory and Clinical Research Developments)

£67.64 29 Oct 2026
Advances in Cancer Drug Targets
89% match

Advances in Cancer Drug Targets

£79.95 27 Oct 2026
Squamous cell Carcinoma: Molecular Therapeutic Targets
88% match

Squamous cell Carcinoma: Molecular Therapeutic Targets

Springer

£111.44 22 Oct 2026
Chronic Obstructive Pulmonary Disease: From Diagnosis to Treatment
88% match

Chronic Obstructive Pulmonary Disease: From Diagnosis to Treatment

£156.89 27 Oct 2026
An Introduction to Drug Carriers (Biochemistry Research Trends)
88% match

An Introduction to Drug Carriers (Biochemistry Research Trends)

Price unavailable
Lung Cancer: From Diagnosis to Treatment
88% match

Lung Cancer: From Diagnosis to Treatment

£119.26 27 Oct 2026
Secondary Insults After ICH: From Mechanisms to Clinical Translation
88% match

Secondary Insults After ICH: From Mechanisms to Clinical Translation

Price unavailable
A New Approach to Diagnosis and Treatment of Prostate Cancer
88% match

A New Approach to Diagnosis and Treatment of Prostate Cancer

£110.26 27 Oct 2026
Clinical Oncology: New Paradigms
88% match

Clinical Oncology: New Paradigms

£119.74 27 Oct 2026
Rett Syndrome (RTT): From Diagnosis to Treatment (Health Psychology Research Focus)
88% match

Rett Syndrome (RTT): From Diagnosis to Treatment (Health Psychology Research Focus)

Price unavailable
Transformer le traitement du cancer Des matériaux intelligents aux thérapies géniques
88% match

Transformer le traitement du cancer Des matériaux intelligents aux thérapies géniques

£68.99 19 Nov 2026
Brain Tumors: Therapeutics and Management
88% match

Brain Tumors: Therapeutics and Management

£110.59 27 Oct 2026
Advances in Cancer Drug Targets: Volume 1
88% match

Advances in Cancer Drug Targets: Volume 1

£77.33 27 Oct 2026
Ovarian Cancer: Progression, Diagnosis and Treatment
87% match

Ovarian Cancer: Progression, Diagnosis and Treatment

£111.48 27 Oct 2026
Current Progress in Cancer Treatments
87% match

Current Progress in Cancer Treatments

£120.55 02 Nov 2026
Onco-critical Care: An Evidence-based Approach
87% match

Onco-critical Care: An Evidence-based Approach

Springer

£74.21 21 Oct 2026